Spatial learning deficits in Parkinson's disease with and without mild cognitive impairment.

Parkinsonism Relat Disord

Department of Neurology, Technische Universität Dresden, 01307 Dresden, Germany; Department of Neurology, University of Rostock, 18147 Rostock, Germany; German Centre for Neurodegenerative Diseases (DZNE), 18147 Rostock, Germany. Electronic address:

Published: March 2017

Background: Several MRI studies have demonstrated hippocampal atrophy in Parkinson's disease (PD), a structure considered a key element in spatial learning. Despite this, no study has been undertaken to investigate spatial navigation in PD using a virtual version of the Morris water maze, which is the gold standard for testing hippocampal function in rodents.

Methods: We studied 17 cognitively unimpaired PD patients, 12 PD patients with mild cognitive impairment (MCI) and 15 controls in a virtual water maze procedure.

Results: Measured by the main outcome parameters latency to locate the target and heading error (average difference between direction of movement toward anticipated target and real direction toward the target), controls performed significantly better on the virtual water maze task than cognitively unimpaired PD patients or PD patients with MCI, while there was no significant difference between latter two groups.

Conclusions: The virtual water maze test differentiates PD patients from controls, but does not distinguish between cognitively normal and cognitively impaired PD patients, indicating a possible dopamine dependent component in spatial learning. Spatial performance deficits might thus constitute very early signs of dopamine depletion independent of the presence of MCI in Parkinson's disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2016.12.020DOI Listing

Publication Analysis

Top Keywords

water maze
16
spatial learning
12
parkinson's disease
12
virtual water
12
mild cognitive
8
cognitive impairment
8
cognitively unimpaired
8
unimpaired patients
8
patients patients
8
patients
6

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China.

Background: The regulatory role of Trimethylamine-N-oxide (TMAO) for cognition from the perspective of microbiota-gut-brain (MGB) axis in AD remains unclear.

Method: In clinical cohort study for effects of 24-week computerized cognitive training (CCT), registered on clinicaltrials.gov (NCT06094452), plasma TMAO levels were quantified using ELISA in MCI (n=39) and mild AD patients (n=35).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.

Background: To investigate the relationships among plasma biomarkers, basal forebrain, and spatial navigation.

Method: A total of 78 participants were enrolled, including 23 normal controls (NC), 38 subjective cognitive decline (SCD), and 17 mild cognitive impairment (MCI) patients. According to the spatial navigation distance errors in the human version of the Morris Water Maze, the whole cohort was divided into the good spatial navigation performance (gSN) group and the bad spatial navigation performance (bSN) group, with 39 cases in each group.

View Article and Find Full Text PDF

Background: Animal models provide a valuable basis for identification of conserved pathological substrates and processes underlying age-related diseases as well as neurobiological features supporting cognitive resilience in the aging brain. Behavioral measures are a fundamental component in the assessment of cognitive processes but are rarely standardized across laboratories. Currently, there is a scarcity of centralized and standardized data infrastructure for behavioral experiment data collected across laboratories which presents a barrier for data sharing, hypothesis generation, and collaboration.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China.

Background: Microglia play a critical role in the pathogenesis and development of Alzheimer's disease (AD). Selective small-molecule colony-stimulating factor 1 receptors (CSF1R) inhibitor, designed to deplete microglia, could be used to meliorate AD. This study aimed to investigate the effects and mechanisms of chimeric antigen receptor T (CAR-T) cells targeting CSF1R in 6-month-old APP/PS1 male mice.

View Article and Find Full Text PDF

Background: Alzheimer's Disease (AD) is a neurological disease characterized by two major biological components; amyloid beta (abeta) and hyperphosphorylated tau. Research suggests that the hyperphosphorylated tau aggregation seen in late-onset AD is characterized by two independent pathways, one caused by abeta buildup, and the other potentially caused by Apolipoprotein 4 (APOE4). However, research examining the relationship between hyperphosphorylated tau and APOE4 in the absence of abeta has been both inconsistent and lacks behavioral results.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!